8087½ðɳÓ鳡³Ç

8087½ðɳÓ鳡³Ç(Öйú)¹Ù·½ÍøÕ¾

²úÆ·¸ÅÊö

ȾɫÖÊÃâÒß¹²³Áµí£¨Chromatin Immunoprecipitation£¬ChIP£©ÊÇÑо¿ÂÑ°×ÖÊÓëDNAÏ໥×÷Óõľ­µäÊÖÒÕ£¬±»ÆÕ±éÓ¦ÓÃÓÚת¼Òò×ÓÍŽáλµã»ò×éÂÑ°×ÐÞÊÎλµãµÄÑо¿¡£

ÊÖÒÕÁ÷³Ì

8087½ðɳÓ鳡³Ç(Öйú)¹Ù·½ÍøÕ¾

ÆÊÎöÁ÷³Ì

8087½ðɳÓ鳡³Ç(Öйú)¹Ù·½ÍøÕ¾

±¾¹«Ë¾ÓÅÊÆ

1.һվʽЧÀÍ£º
¿Í»§Ö»ÐèÌṩϸ°û»ò×éÖ¯£¬±¾¹«Ë¾ÎªÄúÍê³É´ÓÑùÆ·×¼±¸¡¢ÎÄ¿âÖƱ¸¡¢ÉÏ»ú²âÐòµ½Êý¾ÝÆÊÎöµÄÕûÌ×ЧÀÍÁ÷³Ì¡£
2.ÑÏ¿áµÄÖÊ¿Ø£º
ÑÏ¿áµÄÖÊ¿ØÊÇChIP-SeqʵÑéÀֳɵÄÌõ¼þ¡£±¾¹«Ë¾¶ÔChIP-SeqʵÑéµÄ¸÷¸ö»·½Ú¾ÙÐÐÑÏ¿áµÄÖÊ¿Ø£¬¾¡¿ÉÄܵؽµµÍʵÑéΣº¦¡£
3.ÓÅ»¯µÄChIPÁ÷³Ì£º
ChIP¸»¼¯Ð§ÂÊÊÇChIP-Seq³É°ÜµÄÒªº¦£¬±¾¹«Ë¾½ÓÄÉÉÌÒµ»¯ChIPÊÔ¼ÁºÐºÍÓÅ»¯µÄʵÑéÁ÷³Ì£¬È·±£¿Í»§»ñµÃÓÅ ÖʵÄÊý¾Ý¡£
4.רҵµÄÉúÎïÐÅϢѧÆÊÎö£º
±¾¹«Ë¾¾ßÓÐÇ¿Ê¢µÄÉúÎïÐÅϢѧÍŶÓ£¬Äܹ»Öª×ã¿Í»§µÄÖÖÖÖÉîÈëÊý¾ÝÆÊÎöÐèÇó¡£

Ñù±¾ÒªÇó

Ñù±¾ÀàÐÍ

×éÖ¯£¬Ï¸°ûÑùÆ·»òIP¸»¼¯DNA¡£

ÑùÆ·Á¿

a£©Ï¸°û 5¡Á108
b£©×éÖ¯ 1 g
c£©IP¸»¼¯DNAÖÁÉÙ10 ng

ÑùÆ·ÔËÊä¼°ÉúÑÄ

ÑùÆ·ÔËÊ䣺¸É±ùÔËÊ䣬DNA¿É±ù´üÔËÊ䣻
ÑùÆ·ÉúÑÄ£ºÏ¸°ûÑùÆ·»òÐÂÏÊ×éÖ¯¿é£¨ÇгÉ5-10 mgµÄС¿é£©£¬-80¡æÉúÑÄ£¬ÑùÆ·ÉúÑÄʱ´ú×èÖ¹Öظ´¶³ÈÚ¡£DNA¿É¶ÌÆÚ-20¡æÉúÑÄ¡£

Ïà¹ØÎÄÕÂ

Ô­ÎÄ£ºCell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells

ÆÚ¿¯£ºGenome Research Ó°ÏìÒò×Ó£º10.10
±¾ÎÄͨ¹ýChIP²âÐòϵͳÐÔµØÊÓ²ìÁË11ÖÖ²î±ðÀàÐÍÈËÀàϸ°ûÖÐ3ÖÖת¼Òò×Ó£¨CTCF¡¢RNAPIIºÍMYC£©Óë»ùÒò×éµÄÍŽáÇéÐΡ£Ð§¹ûÅú×¢£ºCTCFÖ÷Ҫ͎áÔÚ»ùÒò¼äÇø£¬¶øRNAPIIºÍMYCÔòÆ«ÏòÓÚÍŽáÔÚºË ÐÄÆô¶¯×ÓÇø¡£CTCFÍŽáλµãÔÚ²î±ðÀàÐÍϸ°ûÖÐÍùÍùûÓжà´óת±ä£¬¶øMYCµÄÍŽáÔò·ºÆðÇ¿ÁÒµÄϸ°ûÌØÒìÐÔ¡£MYCºÍRNAPIIÔÚÐí¶àÇøÓò¹²¶¨Î»£¬²¢¾ßÓÐÐí¶àÅäºÏµÄ°Ð»ùÒò¡£±ðµÄ£¬Í¨¹ýÕûºÏת¼×é²âÐòÊý¾Ý·¢Ã÷£º×ªÂ¼Òò×ÓÍŽáÓëDZÔڰлùÒòµÄ±í´ïÕýÏà¹Ø£¬¶à¸öת¼Òò×ÓµÄ×éºÏ͎ᣬÓÈÆäÊÇMYCºÍRNAPIIµÄͬʱÍŽáÓë»ùÒò¸ß±í´ïÓÐןÜÇ¿µÄ¹ØÁªÐÔ¡£

8087½ðɳÓ鳡³Ç(Öйú)¹Ù·½ÍøÕ¾

Ìṩ¸üºÃµÄЧÀÍ


  • Î÷°²±¾ÍÁ±ê×¼»¯ÊµÑéÊÒ,Õæʵ¿É¿¿µÄЧ¹û

  • ²âÐò׼ȷÐÔ¸ß,ԭʼÊý¾ÝÖÊÁ¿¸ß

  • ȨÍþר¼Ò&¶¥¼âÉúÐÅÍŶÓ&×îºÏÊʵÄÆÊÎö¹¤¾ß

  • ÏîÄ¿ÂÄÀú¸»ºñ,Ò»¶ÔÒ»¶¨ÖÆ»¯¸öÐÔЧÀÍ

  • ½»»¥ÐÔ»ùÒòÉî¶ÈÍÚ¾ò,×îеĶà×éѧÍŽáÆÊÎö¼Æ»®

ÇëÌîдÄúµÄÐèÇó

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿